Limited scalability in the context of cancer refers to the challenges and constraints faced in expanding the availability and effectiveness of cancer treatments to a larger population. This can involve difficulties in making advanced therapies, such as immunotherapy and targeted therapy, widely accessible due to high costs, complex production processes, and logistical barriers.
